Related by context. All words. (Click for frequent words.) 72 mL/min/#.# m 2 70 μg L 69 μg mL 69 #.#mg/dL 69 mIU L 68 pmol L 68 mmol l 68 mIU ml 68 #.#/#.# mmHg [001] 68 corticosteroid dose 68 alanine aminotransferase ALT 67 pg ml 67 microg 67 % CI #.#-#.# [003] 67 ug kg 67 mL kg 67 pmol liter 67 mIU mL 67 mmHg diastolic 67 #μg [001] 67 aspartate aminotransferase AST 67 PSA nadir 67 normal ULN 67 CrCl 66 Acetate Rectal Suppositories 66 pg mL 66 μmol L 66 mcg mL 66 achieved ACR# 66 #mmHg [001] 66 creatinine clearance 66 ALT elevation 66 Hb A1C 66 mEq L 66 glomerular filtration rate 66 fraction LVEF 66 -#.# log# copies mL 66 highest tertile 66 nondiabetic patients 66 μg kg 66 #.#mg/kg [002] 66 SGPT 66 serum sodium concentration 66 sUA 66 μg liter 66 calculated creatinine clearance 66 ml min 66 mmHg systolic 66 ejection fractions 65 hypophosphatemia 65 IU ml 65 salmeterol fluticasone propionate 65 binary restenosis 65 MIC# [001] 65 mm Hg systolic 65 lowest tertile 65 creatinine ratio 65 relapsed MM 65 mU liter 65 serum urate 65 colorectal adenoma 65 mm Hg diastolic 65 ng dL 65 baseline serum creatinine 65 pT3 65 ug ml 65 % Confidence Interval 65 3mg/kg 65 biochemical relapse 65 PROCTOCORT ® Suppository Hydrocortisone 65 -#.# mg dL [002] 65 4mg/kg 65 plasma HCV RNA 65 μg ml 65 -#.# log# 65 urine albumin 64 mmol 64 #mg/day [001] 64 leukocyte count 64 unresectable HCC 64 elevated LDH 64 Cream USP 1 64 HBeAg seroconversion 64 alanine aminotransferase 64 log# copies mL 64 mEq 64 hepatorenal syndrome 64 -#.# ± [002] 64 β blockers 64 aspartate aminotransferase 64 g dl 64 mU L 64 p = NS 64 lopinavir r arm 64 serum phosphorus 64 CI -#.# 64 #.#-#.# [011] 64 glycated hemoglobin levels 64 nmol 64 abacavir lamivudine 64 reduce serum phosphate 64 NNT = 64 QTcF 64 serum HBV DNA 64 estimated glomerular filtration 64 bronchial hyperresponsiveness 64 hemoglobin Hb 64 â ‰ ¥ 64 mcg QD 64 nicardipine 64 confidence interval #.#-#.# 64 PSADT 64 interquartile range 63 mL sec 63 serum aminotransferase levels 63 oxycodone CR 63 statin monotherapy 63 elevated serum creatinine 63 nmol L 63 moderate renal impairment 63 malignancy HCM 63 BENICAR HCT 63 microalbumin test 63 undetectable viral 63 X ULN 63 Index CDAI 63 x ULN 63 salmeterol fluticasone 63 #.#ng/ml 63 hyperphenylalaninemia HPA due 63 rFSH 63 lispro 63 lumbar spine BMD 63 COPD exacerbation 63 mg TID 63 undetectable HBV DNA 63 umol L 63 ertapenem 63 adjunctive placebo 63 #mg BID [003] 63 microbiologically evaluable 63 mm ³ 63 μg d 63 amoxicillin clavulanate 63 albumin excretion 63 HbA1C levels 63 reintubation 63 placebo PBO 63 fluticasone salmeterol 63 nmol liter 63 serum phosphorus levels 63 #mg/kg [002] 63 erosive gastritis 63 certolizumab 63 hours postdose 63 preintervention 63 8mg/kg 63 albumin excretion rate 63 % CI #.#-#.# [007] 63 baseline HbA1c 62 vasopressor 62 placebo dexamethasone 62 μg dL 62 SGOT 62 glycosylated hemoglobin HbA1c 62 severe renal impairment 62 CI #.#-#.# [001] 62 #mg/dl 62 serum phosphorous 62 kg m² 62 HOMA IR 62 mcg albinterferon alfa 2b 62 octreotide LAR 62 baseline Hb 62 HbA 1c 62 lumbar spine bone 62 mmol liter 62 pulmonary exacerbations 62 tolterodine ER 62 aged ≥ 62 IU mL 62 serum phosphate levels 62 non splenectomized 62 uM 62 ARB telmisartan 62 complete cytogenetic response 62 PASI scores 62 mcg BID 62 #mg/dL [002] 62 #.#mmHg 62 iPTH 62 thiazide diuretic 62 Fasting blood glucose 62 #.#g/day 62 sUA levels 62 bioavailable testosterone 62 neutrophil counts 62 budesonide pMDI 62 elevated transaminases 62 log# IU mL 62 pulmonary capillary wedge 62 MBq 62 #mg/day [002] 62 Ishak fibrosis score 62 systolic dysfunction 62 NPH insulin 62 CK MB 62 lopinavir r 62 #mg/kg [001] 62 achieved mucosal healing 62 oral allopurinol 62 Mg Usa 62 ß blockers 62 Primary endpoints 62 mean baseline HbA1c 62 mu g 62 #.#mmol L [002] 62 Nebulized 62 micromoles 62 LVEF 62 normothermic 62 underwent surgical resection 62 BENICAR 62 microbiological eradication 62 confidence intervals CIs 62 inhibitory concentration 62 ACTEMRA TM 62 macroalbuminuria 62 Fasting plasma glucose 62 histologically confirmed 62 mCi 62 infliximab monotherapy 62 KRAS mutations occur 61 echocardiographic parameters 61 mm3 61 heFH 61 prednisone prednisolone plus 61 left ventricular systolic 61 PREZISTA r arm 61 mg/m2/day 61 XIENCE V demonstrated 61 fasting plasma glucose FPG 61 anagrelide 61 REYATAZ r arm 61 euthyroid 61 elevated ALT 61 serum potassium 61 Am J Cardiol 61 Mg Uk 61 CDAI score 61 DAS# CRP 61 min -1 61 Engerix B 61 apolipoprotein B 61 serum magnesium 61 Zometa hazard 61 systolic blood pressures 61 urinary N telopeptide 61 hypervolemic 61 mg BID 61 HbA 1c levels 61 P = .# 61 #Gy 61 ug mL 61 ng ml 61 BMI ≥ 61 mitoxantrone plus 61 % CI #.#-#.# [008] 61 scores TNSS 61 symptomatic intracranial hemorrhage 61 atorvastatin #mg 61 MMSE score 61 #mg/dL [001] 61 severe exacerbations 61 lactate dehydrogenase 61 serum phosphate 61 aminotransferase elevations greater 61 tipranavir r 61 -#.# mg dL [001] 61 #ug [002] 61 #mmHg [002] 61 statistical significance p 61 overt nephropathy 61 #mm Hg 61 mL min 61 Platelet counts 61 mmHg p = 61 aOR 61 serum HCV RNA 61 Serum creatinine 61 morphometric vertebral fractures 61 CR nPR 61 generalized edema 61 Crohn Disease Activity 61 apnea hypopnea index 61 creatine kinase CK 61 milliliters mL 61 mcg linaclotide 61 linoleic acid LA 61 MADRS score 61 systemic corticosteroid 61 CCyR 61 intravenous bolus 61 serum lipid levels 61 fasting triglyceride levels 61 #-#,# mg 61 serum urate levels 61 ATACAND 61 piperacillin tazobactam 61 glycated hemoglobin 61 stage IIIb IV 61 SUVmax 61 dapagliflozin plus 61 severe neutropenia 61 hepatic enzyme 61 titrated glipizide 61 mg/m2 dose 61 flutamide 61 LEXIVA r 61 gm dl 61 fractional shortening 61 Index CDAI score 61 hemoglobin A1c levels 61 steroid dexamethasone 61 fluticasone propionate FP 61 ug g 61 HBV DNA levels 61 ejection fraction EF 61 serum cortisol 61 IIIa inhibitors 61 Plasma concentrations 61 gemcitabine cisplatin 61 #mg q8h 61 pimecrolimus cream 61 ACR# ACR# 60 oral antidiabetic medication 60 atazanavir ritonavir 60 del 5q MDS 60 receiving INTRON 60 serum triglycerides 60 homocysteine concentrations 60 glomerular filtration 60 crossclamp 60 deep venous thromboses 60 FluCAM arm 60 evaluable subjects 60 pharmacologically active isomer 60 mg BID dose 60 serum potassium levels 60 #.#mL 60 XIENCE V PROMUS Stent 60 EDSS score 60 sitosterol 60 PaO 2 60 urate lowering therapy 60 serum PTH 60 diameter stenosis 60 Operative mortality 60 FOLFIRI alone 60 kg -1 60 serum creatinine levels 60 μg g 60 MCyR 60 HbA1c levels 60 plasma triglycerides 60 anemia hemoglobin 60 β blocker 60 graft occlusion 60 aminotransferases 60 OADs 60 zonisamide SR 60 creatine kinase MB 60 mg calcium 60 ml kg 60 VELCADE melphalan 60 microgram kg 60 % CI #.#-#.# [001] 60 mg Androxal 60 imipenem 60 plus prednisone prednisolone 60 detectable HCV RNA 60 adjunctive ABILIFY 60 oxycodone IR 60 exhaled nitric oxide 60 ACE inhibitors beta blockers 60 diastolic BP 60 DAS# remission 60 Apidra ® 60 hematological parameters 60 baseline neutrophil counts 60 #.#/#.# mm Hg [003] 60 nonsignificant difference 60 sotalol 60 Postoperative complications 60 coronary stenosis 60 #ng/ml 60 normotensive 60 tirofiban 60 nadolol 60 tapentadol ER 60 #mg BID [001] 60 μg l 60 % CI #.#-#.# [006] 60 nmol L. 60 serum sodium levels 60 cGy 60 candesartan cilexetil 60 transferrin saturation 60 rheumatoid factor 60 hypokalemia 60 intact parathyroid hormone 60 Scale EDSS score 60 IFN alfa 60 receiving ISENTRESS 60 methacholine challenge 60 lactate dehydrogenase LDH 60 % CI #.#-#.# [004] 60 5-FU/LV 60 ug dose 60 ventricular ejection fraction 60 efavirenz EFV 60 IOP lowering 60 uL 60 baseline FEV 60 #mg QD [002] 60 metoprolol tartrate 60 macrolide antibiotic 60 mg qd 60 erythrocyte sedimentation rate 60 inotropic 60 doxorubicin cyclophosphamide 60 RfD 60 epoetin alpha 60 nonobese 60 dehydroepiandrosterone sulfate 60 diastolic blood pressures 60 chemoradiation therapy 60 ng dl 60 #mg doses [002] 60 hepatic enzymes 60 mg QD 60 hemoglobin A1c HbA1c 60 mcg kg REBETOL 60 autoantibody positive 60 intratympanic 60 asthma exacerbation 60 biphasic insulin aspart 60 hemodynamically significant 60 pulmonary artery pressure 60 μmol l 60 pT2 60 acarbose 60 p = #.# [003] 60 Ejection Fraction 60 inhibitory concentrations 60 comparator arm 60 adefovir treated 60 #μg [002] 60 preoperative PSA 60 systemic hypotension 60 CRp 60 HER2 expression 60 postintervention 60 ritonavir boosted atazanavir 60 definite stent thrombosis 60 + PH# 60 ritonavir boosted 60 J Am Soc 60 kcal d 60 mg hydrochlorothiazide 60 INVEGA ® 60 cells uL 60 CLINICAL STUDIES 60 mg/# hours 59 FEV1 forced expiratory 59 advanced adenoma 59 cells μL 59 mcg ml 59 mucosal healing 59 Alanine 59 metastatic GIST 59 q#h 59 ng mL 59 CDAI 59 Hycamtin ® 59 simvastatin #mg 59 log# reduction 59 lipid lowering agents 59 TAXUS p value 59 μg dl 59 High Dose quadruples 59 ALT flares 59 LDL triglycerides 59 TEAEs 59 #OHD 59 mg kg Hematide 59 leukopenia 59 tumor xenograft models 59 lymphocyte count 59 urinary albumin 59 mild renal insufficiency 59 protein excretion 59 g dL 59 Wistar rats 59 anthracycline taxane 59 beclomethasone dipropionate 59 peginterferon alfa 2a 59 specific antigen PSA 59 xanthine oxidase inhibitor 59 CI #.#-#.# [002] 59 Flu Cy 59 5mg/kg 59 CTAP# Capsules 59 pulmonary arterial 59 pooled comparator 59 LV ejection fraction 59 unfractionated heparin UFH 59 SHPT 59 ìg 59 abdominal circumference 59 serum concentrations 59 deciliter 59 idraparinux 59 Hazard Ratio 59 lymphocytosis 59 aldosterone antagonist 59 mmol L 59 Score DAS# 59 hMG 59 HBeAg negative patients 59 chlorambucil 59 intravesical therapy 59 haematologic 59 baseline LDH 59 neutrophil count 59 leucopenia 59 receiving prophylactic anticoagulation 59 HbA1C 59 progression TTP 59 liver histology 59 #mg/m# [001] 59 antibody titer 59 mCi kg 59 low dose Iluvien 59 TPV r 59 recurrent VTE 59 systolic diastolic blood 59 #ug [001] 59 concentration Cmax 59 #/#mmHg 59 dizziness nausea diarrhea 59 spirometric 59 urinary albumin excretion 59 intravenous diuretics 59 ACR# response 59 nmol l 59 ropivacaine 59 PROCTOCORT ® Cream Hydrocortisone 59 ug L 59 rizatriptan 59 LANTUS R 59 Non inferiority 59 #.#mmol l [002] 59 Pharmacokinetic parameters 59 pg g 59 BUPHENYL R sodium phenylbutyrate 59 detemir 59 serum PSA 59 hsCRP levels 59 AST ALT 59 Naive Patients 59 p = .# [002] 59 onset diabetes mellitus 59 highly emetogenic 59 moderately emetogenic 59 Stage IIB 59 splenectomized 59 indinavir 59 thiazide diuretics 59 baseline A1C 59 -#.# ± [001] 59 transaminase levels 59 systolic BP 59 hemoglobin concentrations 59 Left Ventricular Ejection Fraction 59 femoral neck BMD 59 serum IGF 59 acromegalic patients 59 ACR Pedi 59 oral vancomycin 59 PCWP 59 refractory NSCLC 59 cells mcL 59 bronchoalveolar lavage 59 metformin sulfonylurea 59 CsA 59 nausea somnolence 59 Peg IFN 59 recurrent genital herpes 59 underwent resection 59 Q2W 59 oral antidiabetes 59 hemoglobin hematocrit 59 tissue oxygenation 59 g mL 59 μg dose 59 CTEPH 59 partial remissions 59 arterial thromboembolic events 59 posttransplant 59 pCi l 59 Secondary endpoints included 59 REMICADE monotherapy 59 mcg kg min 59 somatostatin analog 59 Triamcinolone 59 microlitres 59 dexamethasone Decadron 59 sustained virological response 59 BMS p = 59 histologic subtype 59 dalteparin 59 mycophenolate 59 ADCS ADL 59 Ramipril 59 mean baseline A1C 59 serum prostate 59 microliter 59 nanograms milliliter 59 HIV HCV coinfected 59 pyrexia mucositis sepsis febrile 59 mg p = 59 serum LDL cholesterol 59 vitreous floaters 59 timepoints 59 BLLs 58 Creatinine 58 multivariable adjusted 58 Cardiorespiratory fitness 58 AUC0 58 improves glycemic 58 quetiapine risperidone 58 subcutaneous enoxaparin 58 Solid Tumors criteria 58 plus GP IIb 58 FOLFOX6 58 ≥ 58 total thyroidectomy 58 CIMZIA R 58 hypopneas 58 ARCALYST ® 58 fibrin deposition 58 lamivudine monotherapy 58 fasting triglycerides 58 stable angina pectoris 58 Forced expiratory volume 58 #.#mg/kg [001] 58 cough dyspnea 58 malondialdehyde MDA 58 Myelosuppression 58 isolated systolic hypertension 58 postmenopausal osteoporotic women 58 serum calcium 58 paricalcitol 58 Type IIa 58 elevated creatinine 58 normoxic 58 Nephrol Dial Transplant 58 NSTE ACS 58 intravenous bolus injection 58 myocardial infarction ventricular fibrillation 58 PEG IFN 58 primary hypercholesterolemia 58 CC genotype 58 experienced virologic failure 58 adenoma recurrence 58 #mg/#mg 58 triglyceride concentrations 58 cinacalcet 58 FUSILEV enhances 58 oral diclofenac 58 PLX STROKE targeting 58 mycophenolate mofetil 58 eosinophil count 58 median PFS 58 recurrent UTI 58 TURBT 58 Hematocrit 58 total cholesterol triglycerides 58 mcL 58 metabolic alkalosis 58 ACE Inhibitor 58 salivary flow 58 hemoglobin concentration 58 FOLFOX4 58 nondiabetics 58 polyp recurrence 58 parasitaemia 58 pentoxifylline 58 hyperhomocysteinemia 58 Median PFS 58 interferon alfa 2b 58 pretest probability 58 glulisine 58 myalgia arthralgia 58 μg doses 58 transaminases 58 ® lenalidomide 58 eGFR 58 ALT normalization 58 symptomatic GERD 58 ethambutol 58 exhaled NO 58 olmesartan medoxomil hydrochlorothiazide 58 pCR 58 #/#mg 58 micrograms mcg 58 somnolence headache 58 urinary iodine 58 hemodialysis patients 58 Cmax 58 mmHg 58 bacillus Calmette Guerin 58 nanomoles per 58 pretreatment baseline 58 subcutaneously injected 58 mediated dilation 58 mol L 58 cyclophosphamide methotrexate 58 lipid elevations 58 atherogenic dyslipidemia 58 NIHSS 58 plus methotrexate 58 mg m² 58 oral rivaroxaban 58 GH deficiency 58 placebo p = 58 EDARBI 58 RBC transfusions 58 pyrazinamide 58 cytarabine daunorubicin 58 micromolar 58 daunorubicin 58 clodronate 58 #mg/m# [002] 58 tertile 58 intravitreal injections 58 vapreotide acetate 58 maximal doses 58 A1c levels 58 low dose cytarabine 58 fasting plasma 58 serum calcium levels 58 mmol kg 58 Kidney Int 58 atrophic gastritis 58 corrected QT interval 58 #mg dose [002] 58 IR Cysteamine 58 conjunctival hyperemia 58 arterial oxygen saturation 58 log# 58 pretreatment serum 58 thrombocytopenic 58 non valvular atrial 58 mU 58 hydroxymethyl coenzyme 58 dose melphalan 58 serum bilirubin 58 nonfasting triglyceride levels 58 prostate carcinoma 58 #mg #mg #mg [003] 58 Januvia ® 58 undergoing coronary artery 58 estimated GFR 58 posttreatment 58 eplerenone 58 Complication rates 58 P ≤ 58 irbesartan 58 dimensional echocardiography 58 metastatic malignant 58 colorectal carcinoma 58 triglyceride TG 58 micrograms μg 58 SCr 58 gm dL 58 seropositivity 58 progressive dyspnea 58 mg tid 58 seminoma 58 ARCOXIA 58 nasal symptom 58 primary generalized tonic 58 kg/m2 58 NMIBC 58 Hb A1c 58 DAS# [002] 58 elevated lipase 58 urinary cortisol 58 serum testosterone 58 electrical cardioversion 58 serum CRP 58 azilsartan medoxomil 58 virologic response 58 metformin sulphonylurea 58 dacarbazine chemotherapy 58 Arch Intern Med 58 symptomatic VTE 58 Lantus ® 58 LH FSH 58 TMP SMX 58 mg d 58 COMBIVIR 58 NovoLog ® Mix 58 IFN α 58 Biochemical Oxygen Demand 58 deferoxamine 58 millimoles 58 plus aztreonam 58 biologic DMARD 58 tPSA 58 urinary excretion 58 peak VO2 58 tacrolimus ointment 58 serum thyroglobulin 58 elevated alkaline phosphatase 58 postoperative complication 58 carotid artery thickness 58 Nephrol 58 aspirin clopidogrel 58 CIMZIA ™ 58 transaminase elevations 58 isoprostane 58 J Am Coll 58 MAGE A3 ASCI 58 sulfonylurea metformin 58 systemic corticosteroids 58 fosamprenavir 58 urine cytology 58 candidemia 58 lumen diameter 58 6mg 58 Valcyte tablets 58 thromboembolic complications 58 nanomolar 58 achieved CCyR 58 OGTT 58 CLL SLL 58 catheter occlusion 58 saline placebo 58 CIMZIA TM certolizumab pegol 58 diuretic chlorthalidone 58 racemic albuterol 58 neutropenia dehydration dyspnea 58 glycosylated hemoglobin 58 Moli# 58 detrusor overactivity 58 myelodysplastic myeloproliferative diseases 58 kilogram mg kg 58 ribavirin therapy 58 confidence interval CI 57 metformin monotherapy 57 achieved statistical significance 57 mcg kg 57 QTc 57 GnRH agonist 57 nonnucleoside reverse transcriptase inhibitors 57 lanthanum carbonate 57 Apolipoprotein B 57 XP# Transported Prodrug 57 Viread Emtriva Sustiva 57 injected subcutaneously 57 hydroxyvitamin D levels 57 UACR 57 systemic embolism 57 g trans fats 57 aplastic anemia AA 57 mg eq 57 genotypic resistance 57 radical nephrectomy 57 ACR# responses 57 BARACLUDE ® 57 URTI 57 Folfox 57 oral Hycamtin 57 basal bolus therapy 57 folate vitamin B6 57 plasma homocysteine 57 millimoles per 57 IV bolus 57 adriamycin 57 IIIa inhibitor 57 left ventricular LV 57 interferon alfa 2a 57 Interferon beta 1b 57 aspirin heparin 57 endometrial hyperplasia 57 procalcitonin 57 heterozygotes 57 Papillary 57 mRCC 57 inhaled budesonide 57 serum uric acid 57 CIMZIA TM 57 dysuria 57 ischemia driven 57 mg simvastatin 57 spontaneous bowel movements 57 serum folate 57 T2 lesions 57 nitroprusside 57 transaminase elevations greater 57 bacteriuria 57 undetectable HCV RNA 57 receiving highly emetogenic 57 hypercholesterolaemia 57 mcg dL 57 dopamine partial agonist 57 leukocytosis 57 fluorouracil leucovorin 57 transaminase 57 fumarate 57 PRADAXA #mg 57 bypass graft CABG surgery 57 plasma creatinine 57 #mg dose [003] 57 serum bicarbonate 57 mitoxantrone chemotherapy 57 viral titers 57 mmol L. 57 pegylated interferon alfa 57 interleukin IL -6 57 RECIST Response Evaluation Criteria 57 H2RAs 57 triacylglycerol concentrations 57 carotid stenosis 57 attain statistical significance 57 oxygen saturation SpO2 57 CIN3 57 aminotransferase levels 57 AUA Symptom Score 57 tertiles 57 stage IIIB 57 aortic crossclamp 57 per deciliter mg 57 oral hypoglycemic agent 57 serum clusterin levels 57 HIV uninfected 57 ventricular repolarization 57 sputum eosinophils 57 μg m 57 Viread Emtriva 57 radiochemotherapy 57 oxacillin 57 mso footer margin 57 6 mercaptopurine 57 1mg 2mg 57 divalproex sodium 57 subcutaneous insulin 57 Pharmacokinetics PK 57 extracapsular extension 57 plasma leptin 57 bolus dose 57 parous women 57 venlafaxine XR 57 K DOQI 57 fasting glucose levels 57 dose pravastatin 57 XIENCE V vs. 57 nanograms per 57 antithymocyte globulin 57 p ≤ 57 methylprednisolone steroid 57 Montgomery Åsberg Depression 57 g carbo 57 annualized relapse 57 QVAR R 57 hematopoietic cancers 57 serum creatinine 57 patients undergoing CABG 57 impaired glucose metabolism 57 Glomerular filtration rate 57 hydrochlorothiazide HCTZ 57 nevirapine Viramune 57 latent celiac disease 57 #.#mg l [001] 57 TAXUS Express Stent 57 bi ventricular pacing 57 elevated fasting glucose 57 cefazolin 57 intracranial hemorrhage ICH 57 Secondary endpoints include 57 locoregional recurrence 57 oral prednisone 57 adalimumab Humira 57 NIHSS score 57 ischemic cardiomyopathy 57 NYHA Class III